BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 30784924)

  • 1. The effect of Xinkeshu tablets on depression and anxiety symptoms in patients with coronary artery disease: Results from a double-blind, randomized, placebo-controlled study.
    Ma H; Wang Y; Xue Y; Huang D; Kong Y; Zhao X; Zhang M
    Biomed Pharmacother; 2019 Apr; 112():108639. PubMed ID: 30784924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Xinkeshu Improves Endothelial Function and Augments Reendothelialization Capacity in Coronary Artery Disease with Anxiety/Depression.
    Sun J; Zhou M; Lv G; Li W; Liu Y; Liang J; Zhang J; Zhang S; Deng Y; Tao J
    Oxid Med Cell Longev; 2021; 2021():5561272. PubMed ID: 34336100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Xinkeshu tablets on coronary heart disease patients combined with anxiety and depression symptoms after percutaneous coronary intervention: A meta-analysis.
    Chen M; Liu M; Guo X; Zhou J; Yang H; Zhong G; Men L; Xie Y; Tong G; Liu Q; Luan J; Zhou H
    Phytomedicine; 2022 Sep; 104():154243. PubMed ID: 35717809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Jiawei Xiaoyao capsule treatment for mild to moderate major depression with anxiety symptoms: a randomized, double-blind, double-dummy, controlled, multicenter, parallel-treatment trial.
    Su R; Fan J; Li T; Cao X; Zhou J; Han Z; Ma Y
    J Tradit Chin Med; 2019 Jun; 39(3):410-417. PubMed ID: 32186013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Somatic and sociodemographic predictors of depression outcome among depressed patients with coronary artery disease - a secondary analysis of the SPIRR-CAD study.
    Vitinius F; Escherich S; Deter HC; Hellmich M; Jünger J; Petrowski K; Ladwig KH; Lambertus F; Michal M; Weber C; de Zwaan M; Herrmann-Lingen C; Ronel J; Albus C
    BMC Psychiatry; 2019 Feb; 19(1):57. PubMed ID: 30717711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy and safety of Shenzhu Guanxin Recipe Granules for the treatment of patients with coronary artery disease: protocol for a double-blind, randomized controlled trial.
    Jin X; Pan B; Wu H; Wu B; Li Y; Wang X; Liu G; Dang X; Xu D
    Trials; 2019 Aug; 20(1):520. PubMed ID: 31429810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose isoflavone aglycone alleviates psychological symptoms of menopause in Japanese women: a randomized, double-blind, placebo-controlled study.
    Hirose A; Terauchi M; Akiyoshi M; Owa Y; Kato K; Kubota T
    Arch Gynecol Obstet; 2016 Mar; 293(3):609-15. PubMed ID: 26294070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chinese herbal medicine bi min fang for allergic rhinitis: protocol for a double-blind, double-dummy, randomized controlled trial.
    Luo Q; Zhou S; Li X; Chen Q; Lin W; Lu L; Li H; Chen C; Chen W; Li Y
    Trials; 2019 Jan; 20(1):66. PubMed ID: 30658660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-reactive protein and fibrinogen in non-obstructive coronary artery disease as related to depressive symptoms and anxiety: findings from the TweeSteden Mild Stenosis Study (TWIST).
    Mommersteeg PM; Meeuwis SH; Denollet J; Widdershoven JW; Aarnoudse W; Westerhuis BL; Kop WJ
    J Psychosom Res; 2014 Nov; 77(5):426-9. PubMed ID: 25307791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emotional symptoms, quality of life and cytokine profile in hemodialysis patients.
    Montinaro V; Iaffaldano GP; Granata S; Porcelli P; Todarello O; Schena FP; Pertosa G
    Clin Nephrol; 2010 Jan; 73(1):36-43. PubMed ID: 20040350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Shimian granules improve sleep, mood and performance of shift nurses in association changes in melatonin and cytokine biomarkers: a randomized, double-blind, placebo-controlled pilot study.
    Zhang L; Zhang R; Shen Y; Qiao S; Hui Z; Chen J
    Chronobiol Int; 2020 Apr; 37(4):592-605. PubMed ID: 32079428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anxiety and depression in patients with moderate-to-severe psoriasis and comparison of change from baseline after treatment with guselkumab vs. adalimumab: results from the Phase 3 VOYAGE 2 study.
    Gordon KB; Armstrong AW; Han C; Foley P; Song M; Wasfi Y; You Y; Shen YK; Reich K
    J Eur Acad Dermatol Venereol; 2018 Nov; 32(11):1940-1949. PubMed ID: 29706008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Herbal Formulation of Jiawei Xiaoyao for the Treatment of Functional Dyspepsia: A Multicenter, Randomized, Placebo-Controlled, Clinical Trial.
    Chen G; Feng P; Wang S; Ding X; Xiong J; Wu J; Wang L; Chen W; Chen G; Han M; Zou T; Li L; Du H
    Clin Transl Gastroenterol; 2020 Oct; 11(10):e00241. PubMed ID: 33108123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guanxin Danshen Dripping Pills Improve Quality of Life and Cardiovascular Prognoses of CHD Patients after PCI with Anxiety or Depression (GLAD Study): A Randomized Double-Blind Placebo-Controlled Study.
    Wang CL; Huan N; Wang PL; Geng QS; Ma WL; Ma LH; Jiang HY; Meng XP; Zhang DW; Gou XJ; Hu DY; Chen KJ
    Chin J Integr Med; 2023 Mar; 29(3):195-204. PubMed ID: 36301456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validity of the Hospital Anxiety and Depression Scale and Patient Health Questionnaire-9 to screen for depression in patients with coronary artery disease.
    Stafford L; Berk M; Jackson HJ
    Gen Hosp Psychiatry; 2007; 29(5):417-24. PubMed ID: 17888808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rikkunshito simultaneously improves dyspepsia correlated with anxiety in patients with functional dyspepsia: A randomized clinical trial (the DREAM study).
    Tominaga K; Sakata Y; Kusunoki H; Odaka T; Sakurai K; Kawamura O; Nagahara A; Takeuchi T; Fujikawa Y; Oshima T; Kato M; Furuta T; Murakami K; Chiba T; Miwa H; Kinoshita Y; Higuchi K; Kusano M; Iwakiri R; Fujimoto K; Tack JF; Arakawa T
    Neurogastroenterol Motil; 2018 Jul; 30(7):e13319. PubMed ID: 29498457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gender differences in associations of depressive symptoms and anxiety with inflammatory markers in patients with non-obstructive coronary artery disease.
    Mommersteeg PMC; Naudé PJW; Bagijn W; Widdershoven J; Westerhuis BWJJM; Schoemaker RG
    J Psychosom Res; 2019 Oct; 125():109779. PubMed ID: 31421324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Omega-3 Fatty Acids, Depressive Symptoms, and Cognitive Performance in Patients With Coronary Artery Disease: Analyses From a Randomized, Double-Blind, Placebo-Controlled Trial.
    Mazereeuw G; Herrmann N; Oh PI; Ma DW; Wang CT; Kiss A; Lanctôt KL
    J Clin Psychopharmacol; 2016 Oct; 36(5):436-44. PubMed ID: 27529771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationships among pain and depressive and anxiety symptoms in clinical trials of pregabalin in fibromyalgia.
    Arnold LM; Leon T; Whalen E; Barrett J
    Psychosomatics; 2010; 51(6):489-97. PubMed ID: 21051680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Depression and anxiety in patients with coronary artery disease, measured by means of self-report measures and clinician-rated instrument.
    Moryś JM; Bellwon J; Adamczyk K; Gruchała M
    Kardiol Pol; 2016; 74(1):53-60. PubMed ID: 26101024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.